Newsroom-13

Patent on Forskohlin Assigned to Sabinsa Corporation

Sabinsa® Corporation was recently assigned a patent (U.S. Patent #5,804,596, dated September 8, 1998) for the use of forskohlin. The patent titled “Method of preparing forskohlin composition from forskohlin extract and use of forskohlin for promoting lean body mass and treating mood disorders”, describes the use of a composition comprising of 1% to 40% forskohlin (extracted from Coleus forskohlii), in a suitable excipient, to promote lean body mass and treat mood disorders.

Coleus forskohlii is the only known natural source of the unique adenylate cyclase activating phytonutrient, forskohlin. Adenylate cyclase is the enzyme involved in the production of Cyclic Adenosine Monophosphate (cAMP), a significant biochemical agent in metabolic processes Coleus forskohlii.

View Newsletter (PDF)